Literature DB >> 5513972

Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.

J L Skibba, G Ramirez, D D Beal, G T Bryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5513972     DOI: 10.1016/0006-2952(70)90301-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  [Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Authors:  R Preussmann; S Ivankovic; C Landschütz; J Gimmy; E Flohr; U Griesbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

Review 2.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

3.  Clinical pharmacokinetics of high-dose DTIC.

Authors:  J M Buesa; E Urréchaga
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.